Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-001 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00 |
filingDate |
2000-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2002-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abc4659cbc06ccb67efbea18213857d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aac65824fdfee8d54d41e3539d1a663b |
publicationDate |
2002-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6362352-B1 |
titleOfInvention |
F18-labeled thia fatty acids and methods of making and using the same |
abstract |
Sulfur heteroatom substitution at the C4 position of 18F-labeled fatty acids yields a tracer that is retained in proportion to the beta-oxidation rates in mammalian tissue, particularly hypoxic myocardium. Most preferably, the invention is embodied in an [18F]fluoro-4-thia-fatty acid having a chain length of between 8 to 20 carbon atoms. The 18F-labeled 4-thia fatty acids of this invention find particular utility the radiolabelling of tissue sites (e.g., myocardium) for purposes of positron emission tomography. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005123475-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112638868-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015023631-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8554373-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8551445-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011028725-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7776309-B2 |
priorityDate |
1999-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |